04, 2025 (GLOBE NEWSWIRE) -- Noom , the leading digital healthcare company committed to chronic disease prevention and empowering people to live better longer, today announced the launch of the Noom Microdose GLP-1 Rx Program, a groundbreaking offering designed to unlock weight loss and long-term health benefits while minimizing side effects through personalized microdoses of GLP-1 medication, when clinically appropriate
Andres Salumets: Conceptualization, Supervision, Resources, Writingoriginal draft, Writingreview & editing
Also a significant correlation was found between GPX and ALT level
When patients ask about longterm risks, be transparent about what is known and unknown
Medications such as valproic acid, cyclosporine, pivampicillin, and some anti-cancer drugs (e.g., etoposide, vinblastine) can also contribute to carnitine deficiency.[6] Valproic acid therapy may deplete carnitine stores by various mechanisms such as increased urinary excretion as valproylcarnitine, decreased renal tubular reabsorption, and decreased endogenous production